MAPT and Alzheimer disease: GFAP, an astrocytic cytoskeletal protein of which blood levels are increased in individuals with AD and MCI, is upregulated around Aβ plaques and correlates with tau accumulation, indicating its involvement in neuroinflammatory responses and astrocytic reactivity (Kim et al., 2023).